Abstract |
The neurotrophic effects of ebiratide, an ACTH4-9 analog, have been examined using both fetal rat septal cultures and aged rats. The 5-day treatment with ebiratide (10-100 pmol/ml) partially prevented neuronal degeneration that occurred in the cultures in which cells were sparsely plated. Ebiratide (10 pmol/ ml) increased choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities up to 1.5 and 1.2 times the respective control values in the sub-confluent cultures. AChE cytochemistry of the cultures has shown that ebiratide increased the stained area per cell. Ebiratide subcutaneously administered by constant infusion (10 nmol/body/hr) for 4 weeks elevated ChAT activities in the septum (35% over control), neocortex (79%) and hippocampus (89%) of aged rats. Thus, the present study indicates that ebiratide shares neurotrophic properties which may prove beneficial in the therapy for CNS degenerative disorders, especially Alzheimer's disease.
|
Authors | T Matsumoto, S Tsuda, S Nakamura |
Journal | Journal of neural transmission. General section
(J Neural Transm Gen Sect)
Vol. 100
Issue 1
Pg. 1-15
( 1995)
Austria |
PMID | 8748659
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Peptide Fragments
- Adrenocorticotropic Hormone
- ebiratide
- Choline O-Acetyltransferase
- Acetylcholinesterase
|
Topics |
- Acetylcholinesterase
(agonists)
- Adrenocorticotropic Hormone
(analogs & derivatives, pharmacology)
- Age Factors
- Amino Acid Sequence
- Animals
- Brain
(drug effects, ultrastructure)
- Cell Division
- Cells, Cultured
- Cerebral Cortex
(drug effects)
- Choline O-Acetyltransferase
(agonists)
- Female
- Hippocampus
(drug effects)
- Male
- Molecular Sequence Data
- Peptide Fragments
(pharmacology)
- Rats
- Rats, Inbred WKY
- Rats, Sprague-Dawley
- Septum Pellucidum
(drug effects, ultrastructure)
|